Advaxis, Inc. - stock earnings
ADXS Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q2 | -8.7 million USD | 9000 USD |
| 2022Q3 | -10.2 million USD | 91000 USD |
| 2022Q2 | -8.2 million USD | 38000 USD |
| 2022Q1 | -10.0 million USD | 458000 USD |
| 2021Q4 | -10.0 million USD | 1.1 million USD |
| 2021Q3 | -3.3 million USD | 250000 USD |
| 2021Q2 | -5.1 million USD | 1.4 million USD |
| 2021Q1 | -4.0 million USD | 1.6 million USD |
| 2020Q4 | -6.5 million USD | ? USD |
ADXS Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2022 | -14.4 million USD | 250000 USD |
| 2021 | -17.9 million USD | 3.2 million USD |
| 2020 | -26.5 million USD | 253000 USD |
| 2019 | -17.8 million USD | 2.3 million USD |
| 2018 | -66.5 million USD | 6.1 million USD |
| 2017 | -93.4 million USD | 12.0 million USD |
| 2016 | -73.6 million USD | 4.0 million USD |
| 2015 | -47.0 million USD | ? USD |
| 2014 | -16.5 million USD | 1.0 million USD |
| 2013 | -20.0 million USD | ? USD |
| 2012 | -12.1 million USD | ? USD |
| 2011 | -8.1 million USD | ? USD |
| 2010 | -10.8 million USD | 508481 USD |
| 2009 | 929244 USD | 29690 USD |
| 2008 | -5.4 million USD | 65736 USD |
| 2007 | -2.5 million USD | 154201 USD |
| 2006 | -6.2 million USD | 431961 USD |
| 2005 | -1.8 million USD | 552868 USD |
| 2004 | -538076 USD | 116406 USD |
| 2003 | -10000 USD | ? USD |
| 2002 | -10000 USD | ? USD |
ADXS
Price: $0.56
52 week price:
Payout Ratio Range:
Earnings Per Share: -2.51 USD
P/E Ratio: -0.34
Exchange: PNK
Sector: Healthcare
Industry: Biotechnology
Volume: 5364
Ebitda: -27.5 millionMarket Capitalization: 25.9 million